BioCentury | Aug 11, 2011
Targets & Mechanisms
ROS overload
...in a wide range of mouse models of cancer, 1 and the scientists have formed Canthera Therapeutics Inc....
...Lee and Michael Foley, director of the Chemical Biology Platform at the Broad Institute, formed Canthera...
...is nearly insoluble. We had a tough time doing the in vivo experiments," said Mandinova. Canthera...
...Lee and Michael Foley, director of the Chemical Biology Platform at the Broad Institute, formed Canthera...
...is nearly insoluble. We had a tough time doing the in vivo experiments," said Mandinova. Canthera...
